Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1976-02-17
1978-04-11
Rosen, Sam
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
424305, A61K 3119, A61K 31215
Patent
active
040839982
ABSTRACT:
The present invention provides a method for treatment or prophylaxis of certain inflammatory diseases of the mammalian large intestine which comprises administrating a cytoprotective prostaglandin to a mammal who suffers from or is particularly susceptible to said inflammatory diseases of the large intestine. Cytoprotective prostaglandins refer to those prostaglandin-type compounds which are useful in reducing the incidence of NOSAC-induced lesions in the intestinal wall of the rat. "NOSAC" is an abbreviation for "nonsteroidal antiinflammatory compound. "
REFERENCES:
patent: 3903297 (1975-09-01), Robert
patent: 3911124 (1975-10-01), Robert
patent: 3917828 (1975-11-01), Robert
Armitage Robert A.
Rosen Sam
The Upjohn Company
LandOfFree
Treatment of inflammatory diseases of the mammalian large intest does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of inflammatory diseases of the mammalian large intest, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of inflammatory diseases of the mammalian large intest will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-989963